SHARE BUYBACK WEEK 40 2016 Copenhagen, 2016-10-10 11:37

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHARE BUYBACK WEEK 40 2016

Copenhagen, 2016-10-10 11:37 CEST (GLOBE NEWSWIRE) -- Company announcement no. 61

DFDS A/S has in week 40 purchased 56,122 own shares for DKK 18.6m as part of the share buyback programme of DKK 350m launched on 18 August 2016 and expiring latest on 6 February 2017, ref. company announcement no. 50/2016 of 18 August 2016.

The accumulated share buyback of 305,691 shares for DKK 105.0m amounts to 30.0% of the programme.

Period, 2016 No. of shares Average  purchase price Value, DKK
       
Accumulated week 39 249,569 346.03 86,357,174
03 October 10,907 332.00 3,621,100
04 October 6,580 333.25 2,192,780
05 October 11,695 330.17 3,861,287
06 October 11,201 331.78 3,716,249
07 October 15,739 332.77 5,237,432
Total week 40 56,122 331.93 18,628,848
Accumulated week 40 305,691 343.44 104,986,022

Following the purchase, DFDS’ holding of own shares is 2,433,320 equal to 4.1% of the Company’s total no. of shares of 60,000,000. Excluding own shares, the no. of circulating shares is 57,566,680.

The share buyback programme is organised in compliance with the European Commis-sion Regulation 1052/2016 of 8 March 2016 (Safe Harbour regulation for share buy-backs).

Information about all transactions are available in the attachment.

Contact:

         Torben Carlsen, CFO          +45 33 42 32 01                    Søren Brøndholt Nielsen, IR          +45 33 42 33 59

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iBio's Fiscal Year 2024: Innovations and Financial Insights

Updated Category News Views 108

Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....

Continue Reading
Atossa Therapeutics Ready to Present (Z)-Endoxifen Data Soon

Updated Category News Views 129

Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...

Continue Reading
DraftKings Sportsbook Set to Debut at Live! Casino & Hotel

Updated Category News Views 100

Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...

Continue Reading
Transforming Learning Spaces: A Milestone Celebration Ahead

Updated Category News Views 233

Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...

Continue Reading
Velvet Taco Innovates Menu with Exciting New Velvet Bowls

Updated Category News Views 481

Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...

Continue Reading